Pantetheinase is a ubiquitous enzyme that hydrolyzes D-pantothenic acid to cysteamine and pantothenic acid (vitamin B5) through the dissimilating pathway of coenzyme A[1]. The pantetheinase is encoded by the Vnn (vanin) gene, with Vnn1 being the dominant tissue subtype in both mice and humans[2]. Under physiological conditions, membrane-bound pantetheinase is the main source of cysteamine in tissues. Cysteamine is a potent antioxidant, and Vanin/pantetheinase may be involved in the regulation of certain immune functions. Pantothenic acid is an important component of coenzyme A biosynthesis, and coenzyme A is a crucial cofactor involved in the tricarboxylic acid cycle and fatty acid metabolism. Mercaptoethylamine inhibits glutamylcysteine synthetase, thereby reducing the glutathione pool, which may trigger an inflammatory response. Additionally, functional studies of the enzyme have also shown that pantetheinase is involved in liver lipid metabolism, gluconeogenesis, and inflammation[3].
2-Chloropyrimidine-5-carboxylic acid 是 Vanin-1 抑制剂 2 的合成中间体。
PFI-653(Vanin-1-IN-1,compound 3)是一种化学探针,也是一种可结合小鼠、大鼠、狗和人血浆 vanin-1 的 vanin-1 酶抑制剂,而 vanin-1 是一种在代谢和炎症中发挥重要作用的细胞表面相关肌醇(GPi)锚定蛋白,PFI-653 对不同物种来源 vanin-1 的 IC50s 分别为 6.85 nM(人重组浆 vanin-1)、9.0 nM(人血浆 vanin-1)、24.5 nM(小鼠重组 vanin-1)和 53.4 nM(小鼠血浆 vanin-1)。
RR6 是一种有效、选择性、可逆、竞争性且具有口服活性的 vanin 抑制剂,对重组 vanin-1 的 IC50 为 540 nM,同时还能有效抑制人、牛和大鼠血清泛酶,IC50 值分别为 40 nM、41 nM 和 87 nM。
Vanin-1-IN-2 是一种有效的 vanin-1 抑制剂(IC50 为 162 nM),而 vanin-1 是一种细胞表面相关的糖基磷脂酰肌醇 (GPI) 锚定蛋白,在肾脏、肝脏和小肠中高水平表达。
Vanin-1-IN-4(化合物 (S)-1)是一种带有手性甲基取代基的 vanin-1 抑制剂,作为有效的候选药物,其以无定形固体形式存在。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号